SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
VIR

Vir Biotechnology, Inc. (VIR)

NASDAQ: VIR · Real-Time Price · USD
Healthcare · Biotechnology
10.95+0.38 (+3.55%)
 
Market cap
$1.85B
Analyst consensus
Website
Insider Score
––Not scored
VIR Insider Score

Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

VIR Income Statement

Fiscal PeriodQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025
Revenue238.95 M-29.00 K64.07 M240.00 K1.21 M3.03 M
Revenue Growth (YoY)19582.54 %-100.96 %417.78 %-89.92 %-60.52 %-94.62 %
Cost of Revenue2.80 M2.81 M2.92 M2.99 M2.93 M2.87 M
Gross Profit236.14 M-2.84 M61.15 M-2.75 M-1.71 M165.00 K
SG&A Expense30.20 M23.34 M23.62 M22.23 M22.28 M23.94 M
R&D Expense131.35 M107.00 M85.53 M147.91 M84.61 M114.75 M
Operating Expenses161.55 M130.34 M109.15 M170.14 M106.89 M138.69 M
Operating Income74.60 M-133.18 M-48.00 M-172.88 M-108.61 M-138.53 M
Pretax Income80.26 M-125.53 M-43.06 M-162.97 M-110.79 M-120.95 M
Tax Provision179.00 K170.00 K-137.00 K168.00 K170.00 K16.00 K
Net Income80.08 M-125.69 M-42.92 M-163.14 M-110.96 M-120.97 M
EPS (Basic)0.48-0.85-0.31-1.17-0.80-0.88
EPS (Diluted)0.47-0.85-0.31-1.17-0.80-0.88
Shares Outstanding167.72 M147.36 M139.23 M138.93 M138.45 M137.47 M

Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.